FR2338935A1 - Bis-(n-oxydes) de quinoxalines utilisables comme substances actives de medicaments - Google Patents

Bis-(n-oxydes) de quinoxalines utilisables comme substances actives de medicaments

Info

Publication number
FR2338935A1
FR2338935A1 FR7701398A FR7701398A FR2338935A1 FR 2338935 A1 FR2338935 A1 FR 2338935A1 FR 7701398 A FR7701398 A FR 7701398A FR 7701398 A FR7701398 A FR 7701398A FR 2338935 A1 FR2338935 A1 FR 2338935A1
Authority
FR
France
Prior art keywords
oxides
active substances
medicinal products
quinoxaline
bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7701398A
Other languages
English (en)
French (fr)
Other versions
FR2338935B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH63476A external-priority patent/CH627174A5/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2338935A1 publication Critical patent/FR2338935A1/fr
Application granted granted Critical
Publication of FR2338935B1 publication Critical patent/FR2338935B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7701398A 1976-01-20 1977-01-19 Bis-(n-oxydes) de quinoxalines utilisables comme substances actives de medicaments Granted FR2338935A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH63476A CH627174A5 (en) 1976-01-20 1976-01-20 Process for the preparation of quinoxaline di-N-oxide derivatives
CH1492076 1976-11-26

Publications (2)

Publication Number Publication Date
FR2338935A1 true FR2338935A1 (fr) 1977-08-19
FR2338935B1 FR2338935B1 (enExample) 1979-03-23

Family

ID=25685198

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7701398A Granted FR2338935A1 (fr) 1976-01-20 1977-01-19 Bis-(n-oxydes) de quinoxalines utilisables comme substances actives de medicaments

Country Status (21)

Country Link
US (1) US4092415A (enExample)
JP (1) JPS5289683A (enExample)
AU (1) AU515192B2 (enExample)
BR (1) BR7700355A (enExample)
CA (1) CA1108143A (enExample)
DE (1) DE2701707C2 (enExample)
DK (1) DK141509B (enExample)
EG (1) EG13191A (enExample)
ES (1) ES455158A1 (enExample)
FR (1) FR2338935A1 (enExample)
GB (1) GB1569034A (enExample)
HK (1) HK41283A (enExample)
IL (1) IL51292A (enExample)
KE (1) KE3289A (enExample)
MY (1) MY8400251A (enExample)
NL (1) NL7700581A (enExample)
NZ (1) NZ183118A (enExample)
SE (1) SE427928B (enExample)
SG (1) SG28883G (enExample)
SU (1) SU890961A3 (enExample)
YU (2) YU39221B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7869686A0 (it) * 1978-11-24 1978-11-24 Loranze Torino A Procedimento di preparazione di 2metil 3 bidrossietilcarbamollchinossalina i.4 di n ossido puroed altri composti ad esso simili
US4418063A (en) * 1978-12-19 1983-11-29 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides
DE3133888A1 (de) * 1981-08-27 1983-03-10 Bayer Ag Wirkstoffkombination aus kitasamycin und chinoxalin-di-n-oxiden
JPH06701B2 (ja) * 1983-12-01 1994-01-05 旭化成工業株式会社 動物用組成物
EP2644038A1 (en) * 2012-03-26 2013-10-02 DSM IP Assets B.V. Use of para nitro amino derivatives in feed for reducing meth-ane emission in ruminants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670935C3 (de) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carbonsäureamidochinoxalin-1,4-dl-N-oxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Mittel
GB1223720A (en) 1968-10-30 1971-03-03 Ici Ltd Growth promotion
US3635972A (en) * 1969-07-22 1972-01-18 Pfizer 3-methyl-2-quinoxalinecarboxamidedi-n-oxides

Also Published As

Publication number Publication date
NL7700581A (nl) 1977-07-22
ES455158A1 (es) 1978-04-01
SU890961A3 (ru) 1981-12-15
DK141509C (enExample) 1980-09-29
CA1108143A (en) 1981-09-01
YU39221B (en) 1984-08-31
YU13577A (en) 1982-10-31
YU40081B (en) 1985-06-30
KE3289A (en) 1983-06-17
IL51292A (en) 1981-06-29
AU515192B2 (en) 1981-03-19
GB1569034A (en) 1980-06-11
DE2701707A1 (de) 1977-07-21
SE427928B (sv) 1983-05-24
AU2144377A (en) 1978-07-27
NZ183118A (en) 1979-12-11
US4092415A (en) 1978-05-30
DK141509B (da) 1980-04-08
DE2701707C2 (de) 1986-05-22
EG13191A (en) 1980-12-31
IL51292A0 (en) 1977-03-31
BR7700355A (pt) 1977-09-20
MY8400251A (en) 1984-12-31
HK41283A (en) 1983-10-21
SE7700529L (sv) 1977-07-21
JPS5289683A (en) 1977-07-27
FR2338935B1 (enExample) 1979-03-23
SG28883G (en) 1984-04-19
JPS6135985B2 (enExample) 1986-08-15
DK20277A (enExample) 1977-07-21
YU153482A (en) 1982-10-31

Similar Documents

Publication Publication Date Title
BE829845A (fr) Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
BE855405A (fr) Nouvelles 4-amino-4-arylcyclohexanones, leur procede de preparation et medicament les contenant
BE868162A (fr) Amides derives du trimethoxy-3,4,5 benzene et leur application comme medicaments
FR2349566A1 (fr) Nouvelles (1-naphtylalkyl)-amines, leur preparation et leur application comme medicaments
BE860614A (fr) Hydroxylamines alkylees, leur procede de preparation et leur emploi comme medicaments
BE854072A (fr) Nouvelles aminopiperidines, leur preparation et leur emploi comme medicament
FR2353540A1 (fr) Nouveaux benzamides applicables comme medicaments
FR2387221A1 (fr) Derives du benzimidazole utilisables comme substances actives de medicaments veterinaires
BE854171A (fr) 2-imino-thiazolidines et thiazolines utiles comme medicaments
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
LU77548A1 (fr) ((quinolyl-4)-3 propyl-1)-4piperidines,leur preparation et leur utilisation comme medicaments
BE850510A (fr) Bis-(n-oxydes) de quinoxalines utilisables comme substances actives de medicaments
BE868991R (fr) Nouveaux phenylazacycloalcanes utiles comme medicaments
FR2346354A1 (fr) Nouvelles as-triazinobenzodiazepine-1-ones, leur procede de preparation et medicament les contenant
BE823513A (fr) Composes diaziniques utilisables notamment comme substances actives de medicaments
BE803803A (fr) Nouvelles piperazino-pyrimidines utilisables comme medicaments
FR2316949A1 (fr) Derives du benzo-cyclohepta-thiophene, leur preparation et leur application comme medicaments
FR2347925A1 (fr) Medicaments, cosmetiques et pesticides renfermant des fluoroacyl-resorcines
FR2316939A1 (fr) Derives de 2-benzopyranone et leur application comme medicaments
BE862303A (fr) Nouvelles 0-propyloximes substituees basiquement, leur procede de preparation et leur emploi comme medicaments
BE862038A (fr) 1-amino-alkyl inferieur-3,4-diphenyl-1h-pyrazoles et leur utilisation comme medicaments
BE861514A (fr) Derives de la piperazine utilisables comme medicaments
FR2332017A1 (fr) Antibiotiques de type thienamycine utiles comme medicaments
FR2326187A1 (fr) Acyl cyanoguanidines utilisables comme medicaments
FR2322594A1 (fr) Nouvelles 2,3-trans-methylene-15-hydroxy-prostaglandines, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse